Chest computed tomography-derived low fat-free mass index and mortality in COPD

Citation:

McDonald M-LN, Diaz AA, Rutten E, Lutz SM, Harmouche R, Estepar RSJ, Kinney G, Hokanson JE, Gower BA, Wouters EFM, et al. Chest computed tomography-derived low fat-free mass index and mortality in COPD. Eur Respir J. 2017;50 (6).

Date Published:

2017 Dec

Abstract:

Low fat-free mass index (FFMI) is an independent risk factor for mortality in chronic obstructive pulmonary disease (COPD) not typically measured during routine care. In the present study, we aimed to derive fat-free mass from the pectoralis muscle area (FFM) and assess whether low FFMIis associated with all-cause mortality in COPD cases. We used data from two independent COPD cohorts, ECLIPSE and COPDGene.Two equal sized groups of COPD cases (n=759) from the ECLIPSE study were used to derive and validate an equation to calculate the FFMmeasured using bioelectrical impedance from PMA. We then applied the equation in COPD cases (n=3121) from the COPDGene cohort, and assessed survival. Low FFMIwas defined, using the Schols classification (FFMI <16 in men, FFMI <15 in women) and the fifth percentile normative values of FFMI from the UK Biobank.The final regression model included PMA, weight, sex and height, and had an adjusted Rof 0.92 with fat-free mass (FFM) as the outcome. In the test group, the correlation between FFMand FFM remained high (Pearson correlation=0.97). In COPDGene, COPD cases with a low FFMIhad an increased risk of death (HR 1.6, p<0.001).We demonstrated COPD cases with a low FFMIhave an increased risk of death.

Last updated on 04/04/2018